Skip Navigation

Research

Global Projects

Map

RV3-BB neonatal rotavirus vaccine trial


Summary

Clinical dose-ranging trial of a neonatal rotavirus vaccine RV3-BB in Malawi, led by Murdoch Children's Research Institute, University of Melbourne, in collaboration with Centre for Global Vaccine Research, University of Liverpool, UK and the Malawi-Liverpool-Wellcome Trust Clinical Research Programme in Blantyre, Malawi.

Dates

  • Start Date: 
    07/01/2017
  • End Date: 
    12/31/2020

Project Type

Locations

Researchers